Seguir
Ming Tang
Ming Tang
Dana Farber Cancer Institute
Dirección de correo verificada de ds.dfci.harvard.edu - Página principal
Título
Citado por
Citado por
Año
Integrative analysis identifies four molecular and clinical subsets in uveal melanoma
AG Robertson, J Shih, C Yau, EA Gibb, J Oba, KL Mungall, JM Hess, ...
Cancer cell 32 (2), 204-220. e15, 2017
7932017
Systematic analysis of telomere length and somatic alterations in 31 cancer types
FP Barthel, W Wei, M Tang, E Martinez-Ledesma, X Hu, SB Amin, ...
Nature genetics 49 (3), 349-357, 2017
5492017
KRAS-IRF2 axis drives immune suppression and immune therapy resistance in colorectal cancer
W Liao, MJ Overman, AT Boutin, X Shang, DI Zhao, P Dey, J Li, G Wang, ...
Cancer cell 35 (4), 559-572. e7, 2019
4092019
Landscape of EGFR-Dependent and -Independent Resistance Mechanisms to Osimertinib and Continuation Therapy Beyond Progression in EGFR-Mutant NSCLC
X Le, S Puri, MV Negrao, MB Nilsson, J Robichaux, T Boyle, JK Hicks, ...
Clinical Cancer Research 24 (24), 6195-6203, 2018
3362018
Suppression of type I IFN signaling in tumors mediates resistance to anti-PD-1 treatment that can be overcome by radiotherapy
X Wang, JE Schoenhals, A Li, DR Valdecanas, H Ye, F Zang, C Tang, ...
Cancer research 77 (4), 839-850, 2017
2192017
TumorFusions: an integrative resource for cancer-associated transcript fusions
X Hu, Q Wang, M Tang, F Barthel, S Amin, K Yoshihara, FM Lang, ...
Nucleic acids research 46 (D1), D1144-D1149, 2018
1962018
Synthetic essentiality of chromatin remodelling factor CHD1 in PTEN-deficient cancer
D Zhao, X Lu, G Wang, Z Lan, W Liao, J Li, X Liang, JR Chen, S Shah, ...
Nature 542 (7642), 484-488, 2017
1872017
KMT2D deficiency impairs super-enhancers to confer a glycolytic vulnerability in lung cancer
H Alam, M Tang, M Maitituoheti, SS Dhar, M Kumar, CY Han, CR Ambati, ...
Cancer cell 37 (4), 599-617. e7, 2020
1482020
The tandem duplicator phenotype is a prevalent genome-wide cancer configuration driven by distinct gene mutations
F Menghi, FP Barthel, V Yadav, M Tang, B Ji, Z Tang, GW Carter, Y Ruan, ...
Cancer cell 34 (2), 197-210. e5, 2018
1442018
Integrative analyses of single-cell transcriptome and regulome using MAESTRO
C Wang, D Sun, X Huang, C Wan, Z Li, Y Han, Q Qin, J Fan, X Qiu, Y Xie, ...
Genome biology 21, 1-28, 2020
1282020
Single-cell multimodal glioma analyses identify epigenetic regulators of cellular plasticity and environmental stress response
KC Johnson, KJ Anderson, ET Courtois, AD Gujar, FP Barthel, FS Varn, ...
Nature genetics 53 (10), 1456-1468, 2021
1222021
Tumor microenvironment remodeling enables bypass of oncogenic KRAS dependency in pancreatic cancer
P Hou, A Kapoor, Q Zhang, J Li, CJ Wu, J Li, Z Lan, M Tang, X Ma, ...
Cancer discovery 10 (7), 1058-1077, 2020
942020
TRIM29 suppresses TWIST1 and invasive breast cancer behavior
L Ai, WJ Kim, M Alpay, M Tang, CE Pardo, S Hatakeyama, WS May, ...
Cancer research 74 (17), 4875-4887, 2014
932014
MOF acetylates the histone demethylase LSD1 to suppress epithelial-to-mesenchymal transition
H Luo, AK Shenoy, X Li, Y Jin, L Jin, Q Cai, M Tang, Y Liu, H Chen, ...
Cell reports 15 (12), 2665-2678, 2016
882016
USP1 inhibition destabilizes KPNA2 and suppresses breast cancer metastasis
A Ma, M Tang, L Zhang, B Wang, Z Yang, Y Liu, G Xu, L Wu, T Jing, X Xu, ...
Oncogene 38 (13), 2405-2419, 2019
872019
Epithelial-to-mesenchymal transition confers pericyte properties on cancer cells
AK Shenoy, Y Jin, H Luo, M Tang, C Pampo, R Shao, DW Siemann, L Wu, ...
The Journal of clinical investigation 126 (11), 4174-4186, 2016
722016
Evaluating single-cell cluster stability using the Jaccard similarity index
M Tang, Y Kaymaz, BL Logeman, S Eichhorn, ZS Liang, C Dulac, ...
Bioinformatics 37 (15), 2212-2214, 2021
512021
The malignant brain tumor (MBT) domain protein SFMBT1 is an integral histone reader subunit of the LSD1 demethylase complex for chromatin association and epithelial-to …
M Tang, H Shen, Y Jin, T Lin, Q Cai, MA Pinard, S Biswas, Q Tran, G Li, ...
Journal of Biological Chemistry 288 (38), 27680-27691, 2013
512013
Enhancer reprogramming confers dependence on glycolysis and IGF signaling in KMT2D mutant melanoma
M Maitituoheti, EZ Keung, M Tang, L Yan, H Alam, G Han, AK Singh, ...
Cell reports 33 (3), 2020
482020
Histone deacetylase inhibitor targets CD123/CD47-positive cells and reverse chemoresistance phenotype in acute myeloid leukemia
B Yan, Q Chen, K Shimada, M Tang, H Li, A Gurumurthy, JD Khoury, B Xu, ...
Leukemia 33 (4), 931-944, 2019
482019
El sistema no puede realizar la operación en estos momentos. Inténtalo de nuevo más tarde.
Artículos 1–20